4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001209191-23-055521
Chief Scientific Officer acquired 93,718 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Beskrovnaya Oxana Chief Scientific Officer | 2023-11-15 | Grant or award | +93,718 | 178,052 | D | ||
| Derivatives | |||||||
| Beskrovnaya Oxana Chief Scientific Officer | 2023-11-15 | Grant or award · Stock Option (right to buy) | +36,495 | 36,495 | D | ||
Loading xslF345X05/doc4.xml…